Peptides with Soft‐Aggregation Behavior Inhibit and Reverse Amyloid‐β Fibrillization
Small · 2025-09 · 21 (36)
DOI: 10.1002/smll.202505459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 20.07.2025. Verfasst von Sicheng Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Peptides, Protein Aggregates. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Chengdu Municipal Science and Technology Program.
Abstract (Originalsprache)
Amyloid‐β fibrillization, characterized by ordered and compact peptide assembly, is a hallmark and a key therapeutic target of Alzheimer's disease. However, it is still challenging to completely inhibit or even reverse the fibrillization process. Here, it is reported an anti‐fibrillization mechanism mediated by short peptides with a novel soft‐aggregation behavior. Unlike classical peptide self‐assembly forming ordered nanostructures, several peptides derived from an analgesic peptide underwent dynamic self‐aggregation into irregular and loose nanoparticles, which is driven by strong hydrophobic interaction but not by strong hydrogen bonds. By systematically comparing different peptides, it is confirmed a direct correlation between the soft‐aggregation behavior and the anti‐fibrillization efficacy. It is further demonstrated that Ana‐5F, one of these peptides with a superior anti‐fibrillization ability, could bind with two core hydrophobic fragments in amyloid‐β and effectively inhibit their fibrillization. Consequently, Ana‐5F effectively inhibited and reversed fibrillization of full‐length amyloid‐β. In rat models, Ana‐5F cleaned up mature amyloid‐β fibrils and protected the animals from cognitive impairment and anxiety‐like behaviors. This study, for the first time, defined soft‐aggregation as a novel peptide aggregation behavior distinct from classical ordered peptide self‐assembly. It also provided a strategic approach to curing Alzheimer's disease by utilizing the soft‐aggregation mechanism to eliminate pathological amyloid‐β fibrils.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, China.
ORCID-Profile: Feng Qiu
Förderung
- Chengdu Municipal Science and Technology Program
Zitieren
APA
Liu, S., Peng, F., Liu, J., Wu, W., He, L., Cao, H., Liu, C., Qiu, F., & Zhang, W. (2025). Peptides with Soft‐Aggregation Behavior Inhibit and Reverse Amyloid‐β Fibrillization. Small, 21(36). https://doi.org/10.1002/smll.202505459
Vancouver
Liu S, Peng F, Liu J, Wu W, He L, Cao H, et al. Peptides with Soft‐Aggregation Behavior Inhibit and Reverse Amyloid‐β Fibrillization. Small. 2025;21(36). doi:10.1002/smll.202505459
BibTeX
@article{Liu2025,
author = {Liu, Sicheng and Peng, Fei and Liu, Jing and Wu, Weiwei and He, Liu and Cao, Hangxue and Liu, Congyan and Qiu, Feng and Zhang, Wensheng},
title = {Peptides with Soft‐Aggregation Behavior Inhibit and Reverse Amyloid‐β Fibrillization},
journal = {Small},
year = {2025},
volume = {21},
number = {36},
doi = {10.1002/smll.202505459}
}
EUVIMED